This article ties to SDG 3. This resource, created together by Osmosis and the National Organization for Rare Diseases (NORD), aims to increase the knowledge and awareness about the rare disease Langerhans Cell Histiocytosis (LCH), a proliferation of abnormal histiocytes, which are inflammatory immune cells that constantly patrol the body for invaders and can infiltrate multiple body parts including the bones, skin and nervous system.
This short communication reports on a new research agenda for understanding and advancing Planet Health Equity (PHE).
Elsevier,
Smart Nanomaterials to Combat the Spread of Viral Infections
Advanced Strategies for the Prevention of Viral Infections
2023, Pages 97-123
This content supports the SDG Goal 3: Good health and well-being by discussing the role of multifunctional metal nanoparticles as antiviral therapeutic agents and nanovaccines against different viruses, including human immunodeficiency virus, hepatitis viruses, influenza A virus, herpes simplex virus, and severe acute respiratory syndrome coronavirus 2.
This content supports the SDG Goal 3: Good health and well-being by exploring the human hepatitis B virus (HBV), family Hepadnaviridae, as a highly infectious virus transmitted by blood and body fluids.
Elsevier,
Genomic Data Sharing, Case Studies, Challenges, and Opportunities for Precision Medicine, 2023, Pages 71-90
The Global Alliance for Genomics and Health (GA4GH) is an international standards development organization focused on advancing human health and medicine through genomic data sharing and interoperability. Founded in 2013, the organization has evolved over time and has adapted to unexpected challenges. Three themes have emerged as critical to the organization's success: (1) community needs must drive development; (2) agility is necessary to create global equity and opportunity; (3) developing an idea into a widely adopted standard requires multiple levels of consensus furthering SDG3.
This chapter advances the UN SDG goal 3 and 17 by exploring antiogensin in relation to the treatment of neurological disorders
This chapter advances the UN SDG goals 3 and 17 discusses the female gender on AD risk.
This chapter advances the UN SDG goals 3 and 17 discusses the effects COVID had on the lifestyle of patients with AD.
This chapter advances the UN SDG goals 3 and 17 by reviewing the use of cannabidiol oil for AD patients.
A patient survey identified unmet global needs in CLL and can guide patient education targets for clinicians, advocates, and policymakers.
